SCHEMBL9719784

SCHEMBL9719784

Nc1ccccc1OCc1ccccn1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 11/20 0.58
ABCB1 P08183 1/20 0.55
HTR1A P08908 1/20 0.55
DRD2 P14416 1/20 0.55
AURKB Q96GD4 3/20 0.53
INCENP Q9NQS7 3/20 0.53
ALDH1A1 P00352 3/20 0.50
APP P05067 1/20 0.50
PARP10 Q53GL7 1/20 0.47
KDM4E B2RXH2 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
LTA4H P09960 1/20 0.46
MAPK14 Q16539 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
HRH1 P35367 1/20 0.46
ADRA2B P18089 1/20 0.45
PTGS1 P23219 1/20 0.45
TDP1 Q9NUW8 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9117255 0.84 LTA4H (0.67) SYKABCB1HTR1ADRD2AURKB
SCHEMBL7542452 0.80 MGMT (0.49) SYKABCB1HTR1ADRD2AURKB
SCHEMBL8308720 0.78 SYK (0.51) SYKABCB1HTR1ADRD2AURKB
SCHEMBL9719880 0.78 SYK (0.58) SYKABCB1HTR1ADRD2AURKB
SCHEMBL25319633 0.78 RAB9A (0.56) SYKABCB1HTR1ADRD2AURKB
SCHEMBL12301166 0.78 SYK (0.62) SYKABCB1HTR1ADRD2AURKB
SCHEMBL10855730 0.78 ABCB1 (0.55) SYKABCB1HTR1ADRD2AURKB
SCHEMBL4342702 0.78 SYK (0.67) SYKABCB1HTR1ADRD2AURKB
SCHEMBL21465846 0.78 SYK (0.58) SYKABCB1HTR1ADRD2AURKB
SCHEMBL4569960 0.78 SYK (0.59) SYKABCB1HTR1ADRD2AURKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9573887-B2 Naphthalene derivative DAITO CHEMIX CORPORATION (JP) 2017-02-21 US disclosed
EP-2599771-B1 NAPHTHALENE DERIVATIVE DAITO CHEMIX CORP (JP) 2016-09-14 EP disclosed
US-20130184241-A1 Naphthalene Derivative KYOTO UNIVERSITY (JP) 2013-07-18 US disclosed
EP-2599771-A1 NAPHTHALENE DERIVATIVE Daito Chemix Corporation (JP) 2013-06-05 EP disclosed
US-5157039-A Lipoxygenase inhibitors LEO PHARMACEUTICAL PRODUCTS LTD. (DK) 1992-10-20 US disclosed
US-5109009-A QUINOLINE AND PYRIDINE COMPOUNDS AND INHIBITION OF 5-LIPOXYGENASES THEREWITH LEO PHARMACEUTICAL PRODUCTS LTD. (DK) 1992-04-28 US disclosed
US-4826987-A Pyridyl and quinoline derivatives LEO PHARMACEUTICAL PRODUCTS LTD. (DK) 1989-05-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130184241-A1 Naphthalene Derivative VCP, NOC2L, VAT1 SYK 4877/4885ABCB1 83/4885HTR1A 4098/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.